2Chidiac C, Bruxelle J, Daures JP, et al. Characteristics of patients with herpes zoster on presentation to practitioners in France [ J ].Clin Infect Dis, 2000,33( 1 ) :62 -69.
3Haanpaa M, Laippala P, Nurmikko T. Allodynia and pinprick hypesthesia in acute herpes zoster, and the development of postherpetic neuralgia[ J]. J Pain Symptom Manage, 2000,20( 1 ) :50 - 85.
4Dworkin RH, Perkins FM, Nagasako EM. Prospects for the prevention of postherpetic neuralgia in herpes zoster patients [ J ]. Clin J Pain, 2000,16(suppl) :90 -100.
5Stankus SJ, Dlugopolski M, Packer D. Management of herpes zoster(shingles) and postherpetic neuralgia[ J]. Am Fam physician,2000,61 (6) :2437 -2444.
6Ormrod D, Goa K. Valaciclovir: a review of its use in the management of herpes zoster[J]. Drugz, 2000,59(6) :1317 -1340.
7Helgason S, Petursson G, Gudmundsson S, et al. Prevalence of postherpetic neuralgia after a first episode of herpes zoster: prospective study with long term follow up. BMJ,2000,321 (7264): 794-796.
8Baron R. Peripheral neuropathic pain: from mechanisms to symptoms.Clin J Pain, 2000 , 16(2 Suppl): S12-20.
9Bonezzi C, Demartini L. Treatment options in postherpetic neuralgia. Acta Neurol Scand Suppl, 1999,173: 25-35.
10Chiarello SE. Tumescent infiltration of corticosteroids, lidocaine, and epinephrine into dermatomes of acute herpetic pain or postherpetic neuralgia. Arch Dermatol, 1998 , 134(3) :279-281.
